1. Home
  2. OCSL vs MPLT Comparison

OCSL vs MPLT Comparison

Compare OCSL & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oaktree Specialty Lending Corporation

OCSL

Oaktree Specialty Lending Corporation

N/A

Current Price

$11.43

Market Cap

1.0B

Sector

Finance

ML Signal

N/A

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$20.02

Market Cap

811.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OCSL
MPLT
Founded
2007
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
811.3M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
OCSL
MPLT
Price
$11.43
$20.02
Analyst Decision
Hold
Strong Buy
Analyst Count
4
4
Target Price
$13.75
$31.00
AVG Volume (30 Days)
788.6K
132.4K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
13.96%
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.30
N/A
P/E Ratio
$190.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.09
$12.24
52 Week High
$16.02
$21.55

Technical Indicators

Market Signals
Indicator
OCSL
MPLT
Relative Strength Index (RSI) 38.28 67.94
Support Level $11.09 $16.17
Resistance Level $13.89 $20.20
Average True Range (ATR) 0.31 1.15
MACD 0.01 0.25
Stochastic Oscillator 33.33 89.56

Price Performance

Historical Comparison
OCSL
MPLT

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.

Share on Social Networks: